⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed
globenewswire.com
ABBV
BMY
AZN
LLY
GILD
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Markets and Competition Outlook 2026-2030: Personalized Medicine Drives Revenue Growth, Reaching $4.61 Billion by 2030
globenewswire.com
AZN
ABBV
BMY
MRK
$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030
globenewswire.com
JNJ
MRK
ABBV
ABT
NVS
GSK
AMGN
TEVA
JAGX
LLY
Cancer Cachexia Market Outlook Report 2026-2030: Personalized Treatments and Digital Tools Elevate Cancer Cachexia Care; Total Revenue to Grow by $600 Million
globenewswire.com
PFE
MRK
ABBV
AZN
SNY
Non-Small Cell Lung Cancer (NSCLC) Global Market Trends and Regional Growth Insights 2026-2030: Rapid Adoption of Targeted Therapies and Immunotherapy Fuels Market Expansion, Reaching $70.8 Billion by 2030
globenewswire.com
PFE
MRK
ABBV
NVS
SNY
BMY
AZN
GSK
Bispecific T-Cell Engagers Market Insights Report (2026-2030) Featuring Strategic Analysis of Pfizer, Johnson & Johnson, Roche, AbbVie, Sanofi and Other Key Players
globenewswire.com
PFE
JNJ
AMGN
ABBV
SNY
REGN
MRK
Pelvic Cancer Induced Hemorrhagic Cystitis Market Poised for Very Strong Growth: Expected to Reach $7.98 Billion by 2030
globenewswire.com
PFE
JNJ
MRK
ABBV
SNY
BMY
AZN
NVS
AMGN
Oncology Precision Medicine Market Trends and Investment Opportunities 2026-2030 - Advancements in CAR-T and Gene Therapies Propel Precision Oncology Growth
globenewswire.com
MCK
ABBV
BMY
ABT
AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting
prnewswire.com
ABBV
Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
globenewswire.com
ABBV
AZN
BIIB
BMY
GSK
LLY
MRK
NVS
SNY
TEVA
UCB